RRX CEO reports stock sale, retains 103K shares and SAR awards
Rhea-AI Filing Summary
Regal Rexnord Corp (RRX) CEO and director reported selling common stock on 11/25/2025. The transactions covered 15,864 shares at a weighted average price of $145.6815, 19,971 shares at a weighted average price of $146.6081, and 100 shares at $147.19. After these sales, the reporting person beneficially owned 103,262.064 shares of Regal Rexnord common stock.
The report states that the shares were sold for tax and estate planning purposes. The reporting person also holds several grants of stock appreciation rights tied to Regal Rexnord common stock, with exercise prices ranging from $133.77 to $168.47 and expiration dates between 02/23/2031 and 02/23/2034, which vest over three years from each grant date.
Positive
- None.
Negative
- None.
Insights
CEO sells 35,935 RRX shares for tax and estate planning; remains a large holder with multiple vested stock appreciation rights.
The CEO and director of Regal Rexnord reported open-market sales of 15,864, 19,971, and 100 shares of common stock on 11/25/2025. Weighted average sale prices were $145.6815 and $146.6081, with one trade at $147.19, indicating sales near the same trading range. Following these transactions, beneficial ownership stood at 103,262.064 common shares, so the individual retains a significant equity stake.
The disclosure explains that the shares were sold for tax and estate planning purposes, which is an administrative reason rather than a stated change in outlook. The report also lists four outstanding grants of stock appreciation rights over 33,374, 32,723, 30,327, and 28,560 underlying shares at exercise prices between $133.77 and $168.47, expiring from 02/23/2031 through 02/23/2034. These awards vest 34% after one year, 67% after two years, and 100% after three years from grant, aligning the executive’s incentives with longer-term share performance.
Overall, this report reflects a sizable but explained sale combined with substantial remaining ownership and long-dated equity incentives. Actual implications for market perception depend on how investors weigh insider sales driven by personal financial planning against the continued equity exposure and unexercised stock appreciation rights.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 15,864 | $145.6815 | $2.31M |
| Sale | Common Stock | 19,971 | $146.6081 | $2.93M |
| Sale | Common Stock | 100 | $147.19 | $15K |
| holding | Stock Appreciation Rights | -- | -- | -- |
| holding | Stock Appreciation Rights | -- | -- | -- |
| holding | Stock Appreciation Rights | -- | -- | -- |
| holding | Stock Appreciation Rights | -- | -- | -- |
Footnotes (1)
- These shares were sold for tax and estate planning purposes. The price in Column 4 is a weighted average price. The prices actually received ranged from $145.110 to $146.110. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. The price in Column 4 is a weighted average price. The prices actually received ranged from $146.135 to $147.110. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. The Stock Appreciation Rights vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.
